1. Autophagy and the Insulin-like Growth Factor (IGF) System in Colonic Cells: Implications for Colorectal Neoplasia
    Aldona Kasprzak, 2023, International Journal of Molecular Sciences CrossRef
  2. Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?
    Constantin Stefani et al, 2021, International Journal of Molecular Sciences CrossRef
  3. The Impact of Oxidative Stress and AKT Pathway on Cancer Cell Functions and Its Application to Natural Products
    Jun-Ping Shiau et al, 2022, Antioxidants CrossRef
  4. RPTOR blockade suppresses brain metastases of NSCLC by interfering the ceramide metabolism via hijacking YY1 binding
    Ying Lin et al, 2024, Journal of Experimental & Clinical Cancer Research CrossRef
  5. Suppression of small nucleolar RNA host gene 8 (SNHG8) inhibits the progression of colorectal cancer cells
    Md Zahirul Islam Khan et al, 2023, Non-coding RNA Research CrossRef
  6. HINT3 suppresses AKT/mTOR signaling pathway activity during breast cancer tumorigenesis through PTEN transcriptional activation
    Jinping Li et al, 2023, International Journal of Molecular Medicine CrossRef
  7. Development of novel DNAJB6-KIAA1522-p-mTOR three-protein prognostic prediction models for CRC
    Yu-Juan Jiang et al, 2023, Translational Oncology CrossRef
  8. Orosomucoid 1 promotes colorectal cancer progression and liver metastasis by affecting PI3K/AKT pathway and inducing macrophage M2 polarization
    Lei Yue et al, 2023, Scientific Reports CrossRef
  9. Pathways and molecules for overcoming immunotolerance in metastatic gastrointestinal tumors
    Qixin Gan et al, 2024, Frontiers in Immunology CrossRef
  10. Autophagy in Cancer Therapy: Advances and Prospects
    Soheila Borhani, 2023, Current Molecular Biology Reports CrossRef
  11. Facing Cell Autophagy in Gastric Cancer – What Do We Know so Far?
    Ting Xiu et al, 2021, International Journal of General Medicine CrossRef
  12. Small-molecule drugs of colorectal cancer: Current status and future directions
    Yiren Yang et al, 2024, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
  13. Mechanism of anticancer effect of ETP-45658, a PI3K/AKT/mTOR pathway inhibitor on HT-29 Cells
    Fatih Yulak et al, 2023, Medical Oncology CrossRef
  14. Autophagy in colitis-associated colon cancer: exploring its potential role in reducing initiation and preventing IBD-Related CAC development
    Xuanhong Jin et al, 2024, Autophagy CrossRef
  15. Targeting autophagy in colorectal cancer: An update on pharmacological small-molecule compounds
    Zixiang Li et al, 2022, Drug Discovery Today CrossRef
  16. Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer
    Xin Jin et al, 2024, Acta Pharmaceutica Sinica B CrossRef
  17. Regulated cell death (RCD) in cancer: key pathways and targeted therapies
    Fu Peng et al, 2022, Signal Transduction and Targeted Therapy CrossRef
  18. Rational targeting of autophagy in colorectal cancer therapy: From molecular interactions to pharmacological compounds
    Canhui Jin et al, 2023, Environmental Research CrossRef
  19. DHW-221, a Dual PI3K/mTOR Inhibitor, Overcomes Multidrug Resistance by Targeting P-Glycoprotein (P-gp/ABCB1) and Akt-Mediated FOXO3a Nuclear Translocation in Non-small Cell Lung Cancer
    Mingyue Liu et al, 2022, Frontiers in Oncology CrossRef
  20. Recent advances and limitations of mTOR inhibitors in the treatment of cancer
    Eunus S. Ali et al, 2022, Cancer Cell International CrossRef